Appetite
May reduce appetite and food cravings as part of a broader treatment plan.
Medical weight management
Burn fat. Build confidence. Backed by clinical care.
A modern, medically guided approach to sustainable weight management - built around evaluation, laboratory review, prescription options when appropriate, and consistent support.
The UpOne program
A personalized 6-10 week plan.
For people who have struggled with diets, weight regain, or health conditions related to weight, the program combines medical evaluation with a structured treatment pathway.
- Initial consultation and full physical
- Lab work and blood test review
- Customized weight management plan
- Prescription medication when appropriate
- Follow-up visit at six weeks
- Ongoing clinical support
How GLP-1 care works
Appetite regulation with medical oversight.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and GIP receptors. When prescribed for an appropriate patient, these medications can support reduced appetite and improved fullness.
Satiety
Can increase feelings of fullness and support reduced calorie intake.
Digestion
May slow stomach emptying, which can affect fullness and side effects.
Metabolic care
Some products also support blood sugar management for approved indications.
FDA approval varies by medication, product, and indication. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management in eligible patients. Your clinician will review the specific product, contraindications, benefits, and risks.
Eligibility
Is the program right for you?
Potential candidates may include adults with overweight or obesity, people with related conditions such as type 2 diabetes or hypertension, and those seeking a non-surgical option.
Your clinician determines eligibility after reviewing medical history, current medications, laboratory findings, risks, and goals.
Semaglutide
A GLP-1 medication used for specific approved indications. The source program describes semaglutide as its primary option, with follow-up and laboratory review.
Tirzepatide
A dual GLP-1 and GIP medication that may be considered for eligible patients depending on diagnosis, availability, and clinical judgment.
HCG weight support
The source site lists HCG as an alternative option. Evidence for HCG as a weight-loss treatment is limited, and the FDA has not approved HCG for weight loss. Ask the clinic for a careful discussion of evidence and alternatives.
What results can look like
The legacy program references clinical-trial averages and potential weight loss of up to 15% for some patients. Individual response varies substantially, and no specific result can be guaranteed.
Your program
Safe. Sustainable. Science-informed.
Weight care works best when treatment choice, side-effect management, nutrition, activity, sleep, and follow-up are treated as one clinical picture.
Consult and assess
Review health history, goals, previous approaches, current medications, and potential contraindications.
Complete labs
Use appropriate blood work and examination findings to inform eligibility and baseline health.
Start your plan
Begin the recommended treatment with education about use, side effects, nutrition, and what to monitor.
Follow progress
Return for follow-up, discuss response and tolerability, and adjust the plan if medically appropriate.
New patient offer
Start your weight journey with $100 off.
Ask the clinic to confirm the current 10-week package, promotion, medication, and same-day start availability.